Publication:
How to start insulin treatment: Earlier or delayed insulin therapy

dc.contributor.authorsAkalin, Sema
dc.date.accessioned2022-03-12T15:59:10Z
dc.date.accessioned2026-01-11T08:20:02Z
dc.date.available2022-03-12T15:59:10Z
dc.date.issued2006
dc.description.abstractNo consensus exists as to the best time for starting insulin treatment in patients with type 2 diabetes. Glucose toxicity is a significant factor which affects the approach to treatment at various stages of the disease. Those who advocate early insulin use cite studies which have used CSII or intensive insulin therapy in newly-diagnosed type 2 diabetics and have achieved long-term glycemic control without medication, similar to the honeymoon in type 1 diabetic patients. Although there are studies showing improved control with maximal dose sulfonylurea. therapy, glucose control takes longer to achieve and HbA1c levels remain higher than current targets. It is evident that without insulin, our patients will perpetually remain below target and suffer the consequences of hyperglycaemia, even if mild. (c) 2006 Published by Elsevier Ireland Ltd.
dc.identifier.doi10.1016/j.diabres.2006.06.008
dc.identifier.eissn1872-8227
dc.identifier.issn0168-8227
dc.identifier.urihttps://hdl.handle.net/11424/224313
dc.identifier.wosWOS:000242410600005
dc.language.isoeng
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofDIABETES RESEARCH AND CLINICAL PRACTICE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectearly insulin treatment
dc.subjecttype 2 diabetes mellitus
dc.subjectglucotoxicity
dc.subjectdiabetic complications
dc.subjectTYPE-2 DIABETIC-PATIENTS
dc.subjectTERM GLYCEMIC CONTROL
dc.subjectPANCREATIC-ISLETS
dc.subjectINDUCTION
dc.subjectSECRETION
dc.subjectMORTALITY
dc.titleHow to start insulin treatment: Earlier or delayed insulin therapy
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS19
oaire.citation.startPageS17
oaire.citation.titleDIABETES RESEARCH AND CLINICAL PRACTICE
oaire.citation.volume74

Files